Class Action Lawsuit Details for Hims & Hers Health, Inc.
The Gross Law Firm has issued an important notice to the shareholders of Hims & Hers Health, Inc. (HIMS), informing them about an upcoming class action lawsuit. This notice serves as a reminder for the shareholders who acquired shares during a specified class period to consider their options and understand the implications for their investment.
Shareholder Participation
If you are a shareholder who purchased HIMS shares during the relevant class period, it’s crucial to reach out to the firm for potential lead plaintiff appointments. Note that being appointed as a lead plaintiff is not mandatory to receive any recovery, but contacting the firm can ensure that you are informed about your rights and options moving forward.
Key Dates
The class period extends from April 29, 2025, to June 23, 2025. Consequently, all shareholders should be mindful of the approaching lead plaintiff deadline of August 25, 2025. Early registration is encouraged to secure your place in the proceedings.
Allegations Against Hims & Hers Health, Inc.
The principal allegations outlined in the suit point to claims that during the stated class period, Hims & Hers Health, Inc. and its executives made materially false and misleading statements. Specifically, it's asserted that the company was involved in the deceptive promotion and selling of questionable versions of Wegovy which posed risks to patient safety. Furthermore, these actions led to the termination risk of their collaboration with Novo Nordisk, which has substantial implications for the company's operations and future prospects.
Steps for Shareholders
Once registered, shareholders will benefit from monitoring services that provide updates throughout the case's lifecycle. This service will help keep shareholders informed on any developments or changes, ensuring they remain engaged in the process.
Why Choose The Gross Law Firm?
The Gross Law Firm is recognized nationally for its commitment to investor rights. They stand firmly against corporate deceit and strive to ensure that all companies uphold responsible practices. Their mission encompasses the protection and recovery of investors who have been adversely affected due to misleading corporate statements or fraudulent activities. Enshrined in their practice is a commitment to guide shareholders through complexities involving class actions.
Contact Information
For more information regarding the class action lawsuit or to join the case, shareholders can reach out directly to The Gross Law Firm at:
Address:
15 West 38th Street, 12th Floor
New York, NY 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit concerns allegations against Hims & Hers Health, Inc. related to misleading statements about their products and business practices.
What should I do if I invested in HIMS in the stated class period?
If you purchased HIMS shares during the class period, it is advisable to contact the Gross Law Firm to understand your rights and potential involvement in the class action.
What is the deadline for lead plaintiff registration?
The deadline for registering as a lead plaintiff is August 25, 2025. Early registration is recommended.
Is there a cost to participate in this lawsuit?
No, there is no cost or obligation for shareholders to register and participate in the class action.
How can I stay updated on the lawsuit?
By registering with the firm, shareholders will have access to monitoring services that will provide updates throughout the case lifecycle.
